Literature DB >> 27403788

Low-grade endotoxemia and clotting activation in the early phase of pneumonia.

Roberto Cangemi1, Patrizia Della Valle2, Camilla Calvieri3, Gloria Taliani4, Patrizia Ferroni5, Marco Falcone6, Roberto Carnevale1, Simona Bartimoccia1, Armando D'Angelo2, Francesco Violi7.   

Abstract

BACKGROUND AND
OBJECTIVE: Community-acquired pneumonia (CAP) is associated with an increased risk of arterial and venous thrombosis but the underlying pathophysiological mechanisms are still unclear. We investigated if, in patients with CAP, a pro-thrombotic state does exist and its relationship with serum levels of endotoxins.
METHODS: A total of 104 consecutive patients with CAP were prospectively recruited and followed up until discharge. At admission and at discharge, serum endotoxins, systemic markers of clotting activation and zonulin, a marker of gut permeability, were analysed. Hospitalized patients matched for gender, age and comorbidities but without infections were used as control.
RESULTS: At admission, CAP patients showed higher plasma levels of F1+2 , a marker of thrombin generation (P = 0.023), and lower levels of protein C (PC; P < 0.001) and activated PC (aPC) (P < 0.001) compared with controls. At discharge, plasma levels of both PC and aPC significantly increased while F1+2 significantly decreased (P < 0.001). Baseline serum endotoxins and zonulin were higher in CAP patients than controls (P < 0.001) and significantly decreased at discharge; a significant correlation between serum endotoxins and zonulin was detected (R = 0.575; P < 0.001)
CONCLUSION: This study provides the first evidence that CAP patients disclose an ongoing pro-thrombotic state and suggests a role for endotoxemia in determining enhanced thrombin generation.
© 2016 Asian Pacific Society of Respirology.

Entities:  

Keywords:  endotoxin; pneumonia; protein C; thrombosis; zonulin

Mesh:

Substances:

Year:  2016        PMID: 27403788     DOI: 10.1111/resp.12854

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  5 in total

Review 1.  Year in review 2016: Respiratory infections, acute respiratory distress syndrome, pleural diseases, lung cancer and interventional pulmonology.

Authors:  Marcos I Restrepo; James D Chalmers; Yuanlin Song; Christopher Mallow; Justin Hewlett; Fabien Maldonado; Lonny Yarmus
Journal:  Respirology       Date:  2017-02-28       Impact factor: 6.424

2.  Changes of coagulation function and risk of stroke in patients with COVID-19.

Authors:  Feng Qiu; Yue Wu; Aiqing Zhang; Guojin Xie; Hui Cao; Mingyang Du; Haibo Jiang; Shun Li; Ming Ding
Journal:  Brain Behav       Date:  2021-05-16       Impact factor: 2.708

3.  Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge.

Authors:  Francesco Violi; Daniele Pastori; Roberto Cangemi; Pasquale Pignatelli; Lorenzo Loffredo
Journal:  Thromb Haemost       Date:  2020-04-29       Impact factor: 5.249

4.  Troponin Elevation in Older Patients with Acute Pneumonia: Frequency and Prognostic Value.

Authors:  Alain Putot; Emmanuel Bouhey; Jennifer Tetu; Jérémy Barben; Eléonore Timsit; Sophie Putot; Patrick Ray; Patrick Manckoundia
Journal:  J Clin Med       Date:  2020-11-10       Impact factor: 4.241

5.  Low-Grade Endotoxemia and Thrombosis in COVID-19.

Authors:  Alessandra Oliva; Vittoria Cammisotto; Roberto Cangemi; Domenico Ferro; Maria Claudia Miele; Massimiliano De Angelis; Francesca Cancelli; Pasquale Pignatelli; Mario Venditti; Francesco Pugliese; Claudio Maria Mastroianni; Francesco Violi
Journal:  Clin Transl Gastroenterol       Date:  2021-06-04       Impact factor: 4.488

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.